Unknown

ADENOSCAN^(®)

(Adenosine)

PATIENT INFORMATION LEAFLET

This leaflet provides a summary of the information about the product. If
you have any questions or are not sit, about anything ask your doctor.

What is in this product?

Each 10m vial of Adenoscan contains 30 mg of adenosine. This is in an
isotonic solution of Sodium Chloride in Sterile Water for Injections.

Adenoscan is a sterile solution for infusion into a vein.

Adenoscan increases the amount of blood flowing through the heart
muscle.

+-------------------------------+--------------------------------+
| Adenoscan is manufactured by: | The Product Licence holder is: |
|                               |                                |
| Sanofi Winthrop Industrie     | Sanofi Winthrop Ltd            |
|                               |                                |
| 1 Rue D'Abbaye                | One Onslow Street              |
|                               |                                |
| Notre Dame De Bondeville      | Guildford                      |
|                               |                                |
| France                        | Surrey GU1 4YS                 |
+-------------------------------+--------------------------------+

What is it used for?

Adenoscan increases the amount of blood flowing through the heart muscle
during assessment of heart conditions.

Before use

You should not be given Adenoscan if:

You suffer from asthma.

You know you are allergic to adenosine.

Patients with certain heart conditions should not be given Adenoscan.
Patients with other heart conditions may need special care when
Adenoscan is given. Heart conditions should be discussed with a
specialist before your heart scan s arranged.

If given with some medicines, food or drinks the effects of Adenoscan
may be changed. Please check with your doctor if you are taking any of
the following:

Dipyridamole

Drugs for asthma or bronchitis

You should not drink tea, cola, coffee or cocoa. or eat chocolate for at
least 12 hours before your scan.

Method of use

Adenoscan is given as a single administration into a vein just before
the scan.

The usual quantity is 140 micrograms for every kilogram of your body
weight, per minute, over a period of 6 minutes.

Effects you may notice during administration.

Whilst it is acting on your heart, Adenoscan often causes other effects
which you may notice. There is no need to worry, but you should tell the
doctor if these occur. If the effects become worse the doctor may reduce
the dose or stop the infusion. The effects typically settle within
seconds or minutes after the infusion. Symptoms which have been reported
include:

+----------------------------------+----------------------------------+
| Most commonly                    | Less common                      |
|                                  |                                  |
| Flushing, headache, dizziness,   | Sweating, a congested nose,      |
| light headedness, chest pain,    | nipple discomfort, nervousness,  |
| chest pressure, urge to breathe  | weak arms or legs, tremors,      |
| deeply, discomfort in stomach.   | drowsiness, a buzzing or ringing |
| neck, throat or jaw              | in the ear, blurred vision, dry  |
|                                  | mouth, a metallic taste,         |
|                                  | discomfort in the leg, arm or    |
|                                  | back, weakness or urinary        |
|                                  | urgency, slow heart beat.        |
+----------------------------------+----------------------------------+

Expiry date; do net use after the expiry date shown on the vial. Do not
refrigerate Any portion of vial not used at once should be disposed of.

This leaflet does not contain all the information about your medicine.
Pharmaceutical companies are not able to discuss your personal medical
conditions so if you have any questions, or you are not sure about
anything ask your doctor

Date of last revision of leaflet: March 1995 Adenoscan is a registered
trade mark © 1995 Sanofi Winthrop Ltd

301/227
